Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-EN Version v3-FR
Language English French
Date Updated 2018-09-15 2018-09-07
Drug Identification Number 02367866 02367866
Brand name APO-CANDESARTAN/HCTZ APO-CANDESARTAN/HCTZ
Common or Proper name CANDESARTAN + HCTZ CANDESARTAN + HCTZ
Company Name APOTEX INC APOTEX INC
Ingredients HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE CANDESARTAN CILEXETIL
Strength(s) 12.5MG 16.0MG 12.5MG 16.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C09DA C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2018-09-14 2018-09-14
Remaining supply date 2018-09-14 2018-09-14
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments